mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.007 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.008 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.14 |
0.009 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.009 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.01 |